[{"quiz_id": "ABMS20260101_gemini-3-pro-preview_p03", "question_id": "ABMS20260101_gemini-3-pro-preview_p03-001", "question": "A 32-year-old female is evaluated for palpitations. Labs reveal a TSH of 7.2 mIU/L (High) and Free T4 of 2.9 ng/dL (High). An MRI of the pituitary shows a 5mm hypoenhancing lesion. Sex Hormone Binding Globulin (SHBG) levels are elevated. Which of the following is the most likely diagnosis?", "options": ["Resistance to Thyroid Hormone (RTH) beta", "TSH-secreting pituitary adenoma (TSHoma)", "Graves' disease", "Familial Dysalbuminemic Hyperthyroxinemia", "Heterophile antibody interference"], "answer": "B", "answer_index": 1, "explanation": "Both RTH and TSHoma present with inappropriate TSH secretion (high T4, non-suppressed TSH). The key differentiator is the peripheral tissue response. In TSHoma, peripheral tissues (like the liver) are sensitive to the high thyroid hormone levels, resulting in elevated markers of thyroid action such as Sex Hormone Binding Globulin (SHBG). In RTH, the peripheral tissues are resistant, so SHBG levels are typically normal. The pituitary lesion supports TSHoma, but incidentalomas are common; the metabolic profile (high SHBG) confirms the diagnosis.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Endocrine", "abms_specialty": "Endocrine", "abms_source": "topics_mapped", "source_label_raw": "endocrinology", "source_quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "source_question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-008", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251129T125426901Z_gemini-3-pro-preview_seed123", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T125426901Z_gemini-3-pro-preview_seed123.jsonl", "pred": "B", "model_outputs": "This patient presents with inappropriate TSH secretion (SITSH), characterized by elevated Free T4 and non-suppressed (in this case, elevated) TSH. The differential diagnosis for this lab pattern primarily includes a TSH-secreting pituitary adenoma (TSHoma) and Resistance to Thyroid Hormone (RTH).\n\nTo distinguish between the two:\n1.  Clinical Symptoms: Patients with TSHomas often present with symptoms of hyperthyroidism (palpitations, weight loss, tremor) because the thyroid hormone receptors in peripheral tissues are normal and respond to the excess hormones. Patients with RTH are often euthyroid or hypothyroid, though they can have tachycardia due to receptor subtype differences in the heart.\n2.  MRI Findings: A pituitary lesion supports the diagnosis of an adenoma, although incidentalomas can occur in RTH patients.\n3.  Peripheral Markers of Thyroid Action (Key discriminator):\n    *   Sex Hormone Binding Globulin (SHBG) is produced by the liver in response to thyroid hormones.\n    *   In TSHoma, peripheral tissues (including the liver) are sensitive to thyroid hormone. Consequently, the high T4/T3 levels drive increased production of SHBG, resulting in elevated levels.\n    *   In RTH, the thyroid hormone receptors (specifically TR-beta, which predominates in the liver) are defective. The liver is \"resistant\" to the high thyroid hormone levels, resulting in normal or low SHBG levels.\n\nAnalysis of Options:\n*   A. Resistance to Thyroid Hormone (RTH) beta: While the Labs (High TSH, High T4) fit, the elevated SHBG makes this unlikely, as the liver would be resistant to the hormone signal.\n*   B. TSH-secreting pituitary adenoma (TSHoma): This fits all findings: High TSH and T4 (central hyperthyroidism), pituitary lesion (adenoma), clinical symptoms (palpitations), and crucially, elevated SHBG indicating peripheral tissue hyperthyroidism.\n*   C. Graves' disease: Characterized by suppressed TSH and high T4.\n*   D. Familial Dysalbuminemic Hyperthyroxinemia: Characterized by elevated Total T4 but usually normal TSH and normal Free T4 (depending on the assay), without clinical thyrotoxicosis.\n*   E. Heterophile antibody interference: While possible, the presence of a pituitary lesion, clinical symptoms, and biological markers of thyroid action (SHBG) strongly support a true pathological diagnosis over an assay artifact.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p03", "question_id": "ABMS20260101_gemini-3-pro-preview_p03-002", "question": "A 52-year-old male presents with severe chronic watery diarrhea and 15 kg weight loss over 6 months. He has a history of hypertension treated with olmesartan and amlodipine. Celiac serologies (tTG-IgA, EMA) are negative. Upper endoscopy reveals scalloping of duodenal folds; biopsy shows total villous atrophy and increased intraepithelial lymphocytes. HLA-DQ2 and HLA-DQ8 genotyping is negative. A gluten-free diet for 8 weeks yields no clinical improvement. What is the most likely diagnosis?", "options": ["Refractory Celiac Disease Type 1", "Autoimmune Enteropathy", "Olmesartan-associated Enteropathy", "Common Variable Immunodeficiency (CVID)", "Tropical Sprue"], "answer": "C", "answer_index": 2, "explanation": "Olmesartan-associated enteropathy mimics celiac disease histologically (villous atrophy) but occurs in patients without the genetic predisposition for celiac disease (HLA-DQ2/DQ8 negative). The key discriminator is the medication history and lack of response to gluten withdrawal. Refractory celiac disease requires a prior confirmed diagnosis of celiac disease (positive genetics/serology).", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "abms_specialty": "Gastrointestinal", "abms_source": "target_topic", "source_label_raw": "Gastrointestinal", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-001", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed130.jsonl", "pred": "C", "model_outputs": "This clinical scenario describes a patient with a \"sprue-like\" enteropathy characterized by severe diarrhea, weight loss, and histologic findings of villous atrophy with increased intraepithelial lymphocytes. However, celiac disease is effectively ruled out by the negative tissue transglutaminase (tTG) and anti-endomysial (EMA) antibodies, and crucially, the negative HLA-DQ2 and HLA-DQ8 genotyping (which has a very high negative predictive value). Furthermore, the patient did not respond to a gluten-free diet.\n\nThe key to the diagnosis is the patient's medication history. Olmesartan, an angiotensin II receptor blocker (ARB), is well-documented to cause a severe sprue-like enteropathy. The clinical presentation (chronic diarrhea, weight loss), histologic findings (villous atrophy), and negative celiac workup (serology and genetics) are classic for this condition. Discontinuation of the drug typically leads to clinical and histological recovery.\n\n*   Option A: Refractory Celiac Disease requires a confirmed diagnosis of celiac disease. The negative HLA typing excludes celiac disease.\n*   Option B: Autoimmune enteropathy is rare in adults and is a diagnosis of exclusion; the drug association takes precedence.\n*   Option D: CVID can cause villous atrophy but is usually associated with hypogammaglobulinemia and recurrent infections.\n*   Option E: Tropical sprue requires an appropriate travel history and nutritional deficiencies (B12/folate), which are not mentioned, making the drug-induced etiology more likely.\n\nThe answer is (C)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p03", "question_id": "ABMS20260101_gemini-3-pro-preview_p03-003", "question": "A 34-year-old male presents with progressive dyspnea. He has a BMI of 17 kg/m2. Chest radiography shows apical pleural thickening. High-resolution CT demonstrates upper-lobe predominant subpleural fibrosis and a flattened chest configuration ('platythorax'). He has no history of asbestos exposure or connective tissue disease. Which of the following is the most likely diagnosis?", "options": ["Idiopathic Pulmonary Fibrosis (IPF)", "Pleuroparenchymal Fibroelastosis (PPFE)", "Chronic Hypersensitivity Pneumonitis", "Lymphangioleiomyomatosis (LAM)", "Pulmonary Alveolar Proteinosis"], "answer": "B", "answer_index": 1, "explanation": "Pleuroparenchymal Fibroelastosis (PPFE) is a rare idiopathic interstitial pneumonia characterized by fibrosis of the visceral pleura and subpleural lung parenchyma, predominantly in the upper lobes. The radiographic hallmark is the 'platythorax' (flattening of the chest cage) due to fibrosis progression. This contrasts with IPF (lower lobe predominant) and Hypersensitivity Pneumonitis (mosaic attenuation, centrilobular nodules).", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pulmonary", "abms_specialty": "Pulmonary", "abms_source": "topics_mapped", "source_label_raw": "pulmonology", "source_quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "source_question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-004", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251129T125426901Z_gemini-3-pro-preview_seed123", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T125426901Z_gemini-3-pro-preview_seed123.jsonl", "pred": "B", "model_outputs": "Based on the clinical and radiological presentation, the diagnosis is Pleuroparenchymal Fibroelastosis (PPFE).\n\nHere is the breakdown of the key features supporting this diagnosis:\n1.  Demographics/Physical Exam: The patient is relatively young (34 years old) and has a low BMI (17 kg/m²). PPFE is strongly associated with a slender body habitus.\n2.  Chest Configuration: The \"flattened chest\" or platythorax (decreased anteroposterior diameter) is a hallmark sign of PPFE.\n3.  Radiology: The characteristic imaging findings of PPFE include intense upper-lobe predominant pleural thickening and subpleural fibrosis.\n4.  Exclusions: Idiopathic Pulmonary Fibrosis (IPF) typically affects older adults and shows a lower-lobe predominant pattern. Lymphangioleiomyomatosis (LAM) primarily affects women and presents with cysts rather than fibrosis.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p03", "question_id": "ABMS20260101_gemini-3-pro-preview_p03-004", "question": "A patient with severe chronic hyponatremia (Na 105 mEq/L) and concomitant hypokalemia (K 2.5 mEq/L) is admitted. The resident orders 40 mEq of IV KCl to correct the potassium. Two hours later, the serum sodium has risen to 112 mEq/L, exceeding the safe correction limit. What is the primary physiological mechanism for this rapid rise in serum sodium?", "options": ["Osmotic demyelination releasing sodium", "Intracellular sodium shift in exchange for potassium", "Aldosterone suppression", "Volume expansion suppression of ADH", "Renal sodium retention"], "answer": "B", "answer_index": 1, "explanation": "Administered potassium enters cells to replenish intracellular stores; to maintain electroneutrality, sodium exits the cells into the extracellular space. Therefore, potassium administration acts osmotically equivalent to sodium administration in raising serum tonicity. Additionally, correcting hypokalemia may improve renal concentrating ability, but the cation exchange is the immediate cause of the rapid sodium rise.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Nephrology", "abms_specialty": "Nephrology", "abms_source": "topics_mapped", "source_label_raw": "Nephrology", "source_quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "source_question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-006", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251129T125426901Z_gemini-3-pro-preview_seed125", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T125426901Z_gemini-3-pro-preview_seed125.jsonl", "pred": "B", "model_outputs": "This question addresses the physiological relationship between serum sodium and potassium concentrations, governed by the principles of the Edelman equation:\n$$Na_S = \\frac{Na_E + K_E}{TBW}$$\nWhere $Na_S$ is serum sodium, $Na_E$ is total exchangeable sodium, $K_E$ is total exchangeable potassium, and $TBW$ is total body water.\n\n1.  Patient Physiology: The patient has severe hyponatremia and hypokalemia. In hypokalemia, intracellular potassium stores are depleted. To maintain cell volume and electroneutrality, sodium moves from the extracellular fluid into the cells (and protons may also shift). This intracellular sequestration of sodium lowers the serum sodium concentration.\n2.  Intervention: The patient receives 40 mEq of KCl. Potassium is actively transported into cells via the Na-K-ATPase pump to replenish depleted intracellular stores.\n3.  Mechanism of Sodium Rise: As potassium enters the cells, sodium is pumped out (or shifts out) into the extracellular fluid to maintain electroneutrality and osmotic balance. Physiologically, the administered potassium is osmotically equivalent to sodium regarding its effect on serum tonicity. The entry of potassium into the intracellular space creates a gradient that forces sodium back into the extracellular space.\n4.  Result: This shift of sodium from the intracellular to the extracellular compartment causes a rise in serum sodium concentration. This effect can be significant and rapid, potentially leading to overcorrection (exceeding safe limits) if not accounted for during the treatment of mixed hyponatremia and hypokalemia.\n\nWhy other options are incorrect:\n*   A: Osmotic demyelination is a pathological *consequence* of rapid sodium correction, not the mechanism causing the sodium to rise.\n*   C: Aldosterone suppression would promote sodium loss (natriuresis), which would lower or limit the rise in serum sodium, not cause a rapid spikel.\n*   D: While volume expansion can suppress ADH and lead to free water excretion (aquaresis), 40 mEq of KCl is typically administered in a small volume (e.g., 100-200 mL), which is minimal volume expansion compared to the solute effect. The specific mechanism linking *potassium* administration to a *sodium* rise is the cation exchange.\n*   E: Renal sodium retention is a slower hormonal process and would not account for the immediate and direct effect seen with potassium shifts.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p03", "question_id": "ABMS20260101_gemini-3-pro-preview_p03-005", "question": "A 24-year-old female presents with menorrhagia and prolonged bleeding after a tooth extraction. Coagulation profile shows a prolonged aPTT (55s) and normal PT. Factor VIII activity is 6% (low). von Willebrand Factor (vWF) Antigen is 95% (normal), and vWF Ristocetin Cofactor Activity is 92% (normal). A mixing study corrects the aPTT. Her father has a similar bleeding history, but her brothers are unaffected. What is the most likely diagnosis?", "options": ["Hemophilia A (Carrier state)", "Type 2N von Willebrand Disease", "Type 2A von Willebrand Disease", "Acquired Hemophilia A", "Factor XI Deficiency"], "answer": "B", "answer_index": 1, "explanation": "Type 2N (Normandy) vWD is caused by a defect in the vWF binding domain for Factor VIII, leading to a secondary deficiency of Factor VIII (due to short half-life) despite normal vWF levels and function. It mimics Hemophilia A but exhibits autosomal recessive inheritance (affecting females significantly), whereas Hemophilia A is X-linked. The normal vWF antigen and activity rule out Type 1 and 2A/2B/2M.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Hematology", "abms_specialty": "Hematology", "abms_source": "target_topic", "source_label_raw": "Hematology", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-003", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed130.jsonl", "pred": "B", "model_outputs": "This question describes a female patient with a bleeding diathesis characterized by a specific set of laboratory values:\n1.  Prolonged aPTT and Normal PT: Indicates a defect in the intrinsic pathway.\n2.  Mixing Study Corrects: Indicates a factor deficiency, ruling out inhibitors (like Acquired Hemophilia A).\n3.  Low Factor VIII Activity (6%): This is the specific deficiency.\n4.  Normal vWF Antigen and Ristocetin Cofactor Activity: This indicates that the amount of von Willebrand Factor is normal and its ability to bind platelets is normal.\n\nAnalysis of Options:\n\n*   Hemophilia A (Carrier state): Hemophilia A is an X-linked recessive disorder caused by a deficiency in Factor VIII. Females are typically carriers. While carriers can have reduced Factor VIII levels (often around 50%), a level of 6% is exceptionally low and rare for a simple carrier state, usually requiring extreme skewed X-inactivation (lyonization) or Turner syndrome. While the family history (affected father) fits X-linked inheritance, the severity of the deficiency in a female strongly points to an alternative diagnosis.\n*   Type 2N von Willebrand Disease (Type 2N vWD): Also known as \"Normandy\" type. This is an autosomal recessive disorder where there is a specific defect in the vWF binding domain for Factor VIII. Because vWF cannot bind and protect Factor VIII, the half-life of Factor VIII is significantly reduced, leading to secondary Factor VIII deficiency.\n    *   Lab Profile: Low Factor VIII levels (often <10%), with normal vWF Antigen and normal vWF Ristocetin Cofactor activity. This perfectly matches the patient's labs.\n    *   Presentation: It affects females and males. It is clinically often misdiagnosed as Hemophilia A. In a female presenting with \"Hemophilia A\" phenotype (low FVIII) but normal vWF quantity/platelet function, Type 2N is the classic differential diagnosis.\n*   Type 2A von Willebrand Disease: This involves a deficiency of high-molecular-weight multimers. It typically presents with low vWF Ristocetin Cofactor activity and a mismatch between activity and antigen. This does not fit the patient's normal Ristocetin Cofactor level.\n*   Acquired Hemophilia A: This is caused by autoantibodies (inhibitors). The hallmark is a failure to correct on a mixing study. Since this patient's aPTT corrected, this is excluded.\n*   Factor XI Deficiency: This would cause a prolonged aPTT that corrects with mixing, but the specific finding here is low Factor VIII, not Factor XI.\n\nConclusion:\nThe presentation of a female with significantly low Factor VIII (6%) but normal vWF antigen and functional activity is the textbook presentation for Type 2N von Willebrand Disease. This condition mimics Hemophilia A but follows an autosomal inheritance pattern (unlike Hemophilia A, which is X-linked) and is the most likely diagnosis given the patient's gender and specific lab values.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p03", "question_id": "ABMS20260101_gemini-3-pro-preview_p03-006", "question": "A 19-year-old male presents with recurrent fevers, livedo reticularis, and two episodes of lacunar ischemic stroke. Laboratory evaluation reveals low serum IgM and IgG levels, mild neutropenia, and elevated inflammatory markers. A biopsy of a skin nodule shows necrotizing vasculitis. Genetic testing is most likely to reveal a loss-of-function mutation in which gene?", "options": ["MEFV", "ADA2", "NOD2", "TNFRSF1A", "STAT3"], "answer": "B", "answer_index": 1, "explanation": "This clinical presentation is classic for Deficiency of Adenosine Deaminase 2 (DADA2). It presents with a polyarteritis nodosa (PAN)-like vasculitis, early-onset strokes, and mild immunodeficiency (hypogammaglobulinemia/cytopenias). It is an autosomal recessive autoinflammatory disease. MEFV causes Familial Mediterranean Fever; STAT3 causes Hyper-IgE syndrome.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Immunology", "abms_specialty": "Immunology", "abms_source": "target_topic", "source_label_raw": "Immunology", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-004", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed130.jsonl", "pred": "B", "model_outputs": "The clinical presentation described—recurrent fevers, livedo reticularis, early-onset lacunar ischemic strokes, mild immunodeficiency (low IgM/IgG, neutropenia), and necrotizing vasculitis—is characteristic of Deficiency of Adenosine Deaminase 2 (DADA2).\n\nDADA2 is an autoinflammatory disorder caused by biallelic loss-of-function mutations in the ADA2 gene (formerly known as *CECR1*). The disease pathophysiology involves a lack of ADA2 activity, which leads to uninhibited monocyte differentiation into proinflammatory macrophages and compromise of endothelial integrity. This results in a phenotype that overlaps with polyarteritis nodosa (PAN), explaining the necrotizing vasculitis and stroke risk, along with concurrent hematologic and immunologic abnormalities.\n\n*   MEFV mutations cause Familial Mediterranean Fever.\n*   NOD2 mutations cause Blau syndrome.\n*   TNFRSF1A mutations cause TRAPS (TNF receptor-associated periodic syndrome).\n*   STAT3 mutations are associated with Hyper-IgE syndrome (loss-of-function) or autoimmune lymphoproliferative disorders (gain-of-function).\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p03", "question_id": "ABMS20260101_gemini-3-pro-preview_p03-007", "question": "A 24-year-old male presents with recurrent fevers, livedo racemosa, and acute left hemiparesis. MRI shows a lacunar infarct in the internal capsule. Angiography reveals a 'beads-on-a-string' appearance in the mesenteric and renal arteries. Laboratory evaluation shows low serum IgM and IgG levels. Genetic testing confirms a biallelic loss-of-function mutation in ADA2. Which of the following is the most appropriate maintenance therapy?", "options": ["Cyclophosphamide", "Rituximab", "Etanercept", "Prednisone monotherapy", "Plasma exchange"], "answer": "C", "answer_index": 2, "explanation": "The patient has Deficiency of Adenosine Deaminase 2 (DADA2), which mimics Polyarteritis Nodosa (PAN) but is distinct due to its association with early-onset strokes and hypogammaglobulinemia. Unlike classic PAN, which is treated with cyclophosphamide, DADA2 is driven by TNF-alpha dysregulation. TNF inhibitors (like etanercept) are the treatment of choice and are highly effective in preventing recurrent strokes, whereas cyclophosphamide is often ineffective.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Rheumatology/Musculoskeletal", "abms_specialty": "Rheumatology/Musculoskeletal", "abms_source": "topics_mapped", "source_label_raw": "rheumatology", "source_quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "source_question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-002", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251129T125426901Z_gemini-3-pro-preview_seed124", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T125426901Z_gemini-3-pro-preview_seed124.jsonl", "pred": "C", "model_outputs": "Reflecting on the clinical presentation, the patient has Deficiency of Adenosine Deaminase 2 (DADA2). This is an autosomal recessive disorder caused by loss-of-function mutations in the *ADA2* gene (formerly *CECR1*).\n\nThe clinical features described are classic for DADA2:\n1.  Vasculopathy: 'Beads-on-a-string' appearance on angiography and livedo racemosa, mimicking Polyarteritis Nodosa (PAN).\n2.  Neurologic involvement: Recurrent strokes (lacunar infarcts) are a hallmark, often occurring in childhood or early adulthood.\n3.  Systemic inflammation: Recurrent fevers.\n4.  Immunodeficiency: Hypogammaglobulinemia (low IgM and IgG).\n\nRegarding treatment:\nThe pathophysiology of DADA2 involves an imbalance in monocyte/macrophage differentiation leading to excessive production of pro-inflammatory cytokines, especially Tumor Necrosis Factor-alpha (TNF-$\\alpha$).\n\n*   Options A (Cyclophosphamide) and D (Prednisone): While these are standard treatments for idiopathic Polyarteritis Nodosa (PAN), they have been found to be less effective in DADA2, particularly for preventing recurrent strokes. Patients often suffer recurrent vascular events while on steroids or cytotoxic agents.\n*   Option B (Rituximab): This targets B-cells. Since DADA2 patients often already have hypogammaglobulinemia and B-cell lymphopenia, Rituximab could exacerbate the immunodeficiency and is not the primary treatment for the vasculitic component.\n*   Option C (Etanercept): TNF inhibitors (like etanercept, adalimumab, infliximab) are the treatment of choice for the vasculitis and stroke prevention in DADA2. They have been shown to dramatically reduce the incidence of recurrent strokes, control systemic inflammation, and improve cutaneous symptoms. Hematopoietic stem cell transplantation (HSCT) is considered for severe hematologic or immunologic phenotypes (like bone marrow failure), but for the vasculitis/stroke phenotype presented here, TNF inhibitors are the standard maintenance therapy.\n*   Option E (Plasma exchange): This is not a standard maintenance therapy for this condition.\n\nTherefore, anti-TNF therapy is the most appropriate maintenance therapy to prevent further neurologic injury.\n\nThe answer is (C)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p03", "question_id": "ABMS20260101_gemini-3-pro-preview_p03-008", "question": "A 68-year-old male presents with fever of unknown origin, 15 kg weight loss, and fatigue 4 years after undergoing aortic valve replacement. Labs reveal pancytopenia and elevated liver enzymes. TTE and TEE show no vegetations. PET-CT demonstrates hypermetabolic activity in the spleen and bone marrow. Bone marrow biopsy reveals non-caseating granulomas. Standard blood cultures are negative. Which of the following is the most likely etiology?", "options": ["Sarcoidosis", "Culture-negative endocarditis (HACEK group)", "Mycobacterium chimaera", "Tropheryma whipplei", "Late-onset prosthetic valve thrombosis"], "answer": "C", "answer_index": 2, "explanation": "This is the classic presentation of disseminated *Mycobacterium chimaera* infection associated with contaminated heater-cooler units used during cardiopulmonary bypass. The incubation period can be several years. It presents with systemic symptoms, cytopenias, and granulomatous inflammation (often misdiagnosed as sarcoidosis). Diagnosis requires specific mycobacterial blood cultures or tissue PCR.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Infectious Disease", "abms_specialty": "Infectious Disease", "abms_source": "topics_mapped", "source_label_raw": "Infectious Disease", "source_quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "source_question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-004", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251129T125426901Z_gemini-3-pro-preview_seed124", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T125426901Z_gemini-3-pro-preview_seed124.jsonl", "pred": "C", "model_outputs": "This patient presents with a constellation of findings consistent with disseminated _Mycobacterium chimaera_ infection.\n\nHere is the breakdown of the clinical reasoning:\n1.  Epidemiology and Risk Factor: The patient underwent aortic valve replacement 4 years ago. Since approximately 2013, there has been a recognized global outbreak of _M. chimaera_ infections linked to contaminated heater-cooler units (HCUs) used during cardiopulmonary bypass.\n2.  Latency: These infections are characterized by a long latency period, typically presenting months to years (median 15-18 months, but up to 5-6 years) after the index surgery.\n3.  Clinical Presentation: The classic triad involves fever, fatigue, and weight loss. Other manifestations include splenomegaly, pancytopenia (due to bone marrow infiltration), and elevated liver enzymes.\n4.  Pathology: Biopsies of involved tissues (bone marrow, liver, lymph nodes) typically demonstrate non-caseating granulomas, which can lead to a misdiagnosis of sarcoidosis.\n5.  Microbiology: _M. chimaera_ is a slow-growing non-tuberculous mycobacterium. Standard blood cultures indicate bacterial negativity (as seen in this case). Diagnosis requires acid-fast bacilli (AFB) blood cultures or PCR.\n6.  Imaging: PET-CT is useful for detecting extra-cardiac dissemination, often showing uptake in the spleen, bone marrow, or vascular graft sites, even if echocardiography does not show frank vegetations.\n\nWhy other options are less likely:\n*   Sarcoidosis (A) shares histological features (non-caseating granulomas) and can cause systemic symptoms. However, in a patient with prior resulting cardiac surgery presenting with these severe systemic signs, _M. chimaera_ is the critical diagnosis to rule out. It is often described as a sarcoid-like illness.\n*   Culture-negative endocarditis (HACEK) (B) would typically present with valvular vegetations on TEE and is less likely to cause extensive bone marrow granulomatosis.\n*   _Tropheryma whipplei_ (D) (Whipple's disease) can cause culture-negative endocarditis and systemic symptoms, but the histology is characterized by PAS-positive foamy macrophages, not typical non-caseating granulomas.\n*   Prosthetic valve thrombosis (E) presents with mechanical obstruction or embolic phenomena, not a granulomatous inflammatory process with fever and weight loss.\n\nThe answer is (C)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p03", "question_id": "ABMS20260101_gemini-3-pro-preview_p03-009", "question": "A 65-year-old male with metastatic colorectal cancer is being evaluated for third-line therapy. Molecular profiling reveals the tumor is KRAS wild-type, NRAS wild-type, and BRAF V600E mutated. Microsatellite status is stable (MSS). Which of the following regimens is the most appropriate targeted therapy?", "options": ["Vemurafenib monotherapy", "Encorafenib plus Cetuximab", "Dabrafenib plus Trametinib", "Pembrolizumab monotherapy", "Regorafenib monotherapy"], "answer": "B", "answer_index": 1, "explanation": "In BRAF V600E-mutated colorectal cancer, BRAF inhibitor monotherapy (e.g., Vemurafenib) is ineffective due to a feedback loop that causes rapid upregulation of EGFR signaling. The standard of care, based on the BEACON trial, is the combination of a BRAF inhibitor (Encorafenib) and an EGFR inhibitor (Cetuximab) to block this feedback loop. Pembrolizumab is only for MSI-High tumors.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Medical Oncology", "abms_specialty": "Medical Oncology", "abms_source": "target_topic", "source_label_raw": "Medical Oncology", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-005", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed130.jsonl", "pred": "B", "model_outputs": "Based on the NCCN guidelines and the results of the BEACON CRC trial, patients with metastatic colorectal cancer harboring the BRAF V600E mutation (who are MSI-Stable) benefit most from the combination of a BRAF inhibitor and an anti-EGFR antibody.\n\n1.  Vemurafenib monotherapy (A) is not effective in colorectal cancer due to feedback activation of EGFR signaling when BRAF is inhibited alone.\n2.  Encorafenib plus Cetuximab (B) is the FDA-approved regimen for adult patients with metastatic colorectal cancer with a BRAF V600E mutation, as detected by an FDA-approved test, after prior therapy. The BEACON CRC trial demonstrated superior overall survival with this combination compared to the control arm.\n3.  Dabrafenib plus Trametinib (C) is used in melanoma and NSCLC but is not the standard selected regimen for colorectal cancer, primarily because successful blockage requires addressing the EGFR feedback loop (usually requiring an anti-EGFR antibody component).\n4.  Pembrolizumab monotherapy (D) is indicated for patients with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) tumors. Since this patient is MSS (Microsatellite Stable), immunotherapy is not the appropriate choice.\n5.  Regorafenib monotherapy (E) is a standard third-line treatment for refractory mCRC, but in the presence of a targetable BRAF V600E mutation, the targeted regimen (Encorafenib + Cetuximab) offers better response rates and survival outcomes.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p03", "question_id": "ABMS20260101_gemini-3-pro-preview_p03-010", "question": "A 45-year-old male presents with recurrent episodes of hypotension and syncope occurring 3 to 6 hours after eating dinner. He has no history of atopy. Skin prick tests to beef, pork, and lamb are negative, but intradermal testing is positive. Serum tryptase is normal. Specific IgE testing reveals elevated IgE to galactose-alpha-1,3-galactose. Which of the following is the most likely vector for sensitization in this patient?", "options": ["Ixodes scapularis (Black-legged tick)", "Amblyomma americanum (Lone Star tick)", "Dermacentor variabilis (American Dog tick)", "Aedes aegypti (Mosquito)", "Ctenocephalides felis (Cat flea)"], "answer": "B", "answer_index": 1, "explanation": "This is Alpha-gal syndrome, a delayed anaphylactic reaction to mammalian meat (red meat) mediated by IgE against the alpha-gal carbohydrate. Sensitization is caused by bites from the Lone Star tick (*Amblyomma americanum*) in the US. The reaction is characteristically delayed (3-6 hours) unlike typical protein-based food allergies.", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Allergy/Immunology", "abms_specialty": "Allergy/Immunology", "abms_source": "target_topic", "source_label_raw": "Allergy/Immunology", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-006", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed130.jsonl", "pred": "B", "model_outputs": "This patient presents with signs and symptoms consistent with Alpha-gal syndrome (galactose-alpha-1,3-galactose allergy). Key features include:\n*   Delayed Anaphylaxis: Reactions typically occur 3 to 6 hours after consuming mammalian meat (beef, pork, lamb), unlike typical food allergies which occur within minutes.\n*   Testing Discrepancy: Skin prick tests can sometimes be negative or equivocal, while intradermal tests are positive.\n*   Specific IgE: The diagnostic hallmark is elevated IgE to the carbohydrate moiety galactose-alpha-1,3-galactose (alpha-gal).\n\nSensitization to the alpha-gal carbohydrate is caused by the bite of certain ticks. In the United States, the primary vector associated with this sensitization is _Amblyomma americanum_, commonly known as the Lone Star tick.\n\n*   Option A (_Ixodes scapularis_): While _Ixodes_ species (e.g., _I. ricinus_ in Europe, _I. holocyclus_ in Australia) are vectors for alpha-gal sensitization in other parts of the world, _Amblyomma americanum_ is the operative vector in North America.\n*   Option C (_Dermacentor variabilis_): This tick transmits Rocky Mountain spotted fever and tularemia but is not the primary cause of alpha-gal sensitization.\n*   Options D and E: Mosquitoes and fleas are not vectors for alpha-gal sensitization.\n\nThe answer is (B)"}]